22157.jpg
The Worldwide PET-CT Scanner Device Industry is Expected to Reach $2.6 Billion by 2027
April 14, 2022 07:28 ET | Research and Markets
Dublin, April 14, 2022 (GLOBE NEWSWIRE) -- The "Global PET-CT Scanner Device Market Size, Share & Industry Trends Analysis Report By Slice Count, By Isotope/Detector Type, By Service Provider,...
Global Nuclear Imaging Equipment Market Analysis & Forecasts, 2016-2021 & 2022-2026
March 07, 2022 06:48 ET | Research and Markets
Dublin, March 07, 2022 (GLOBE NEWSWIRE) -- The "Global Nuclear Imaging Equipment Market, By Product Type (PET Imaging Systems, Gamma Camera Imaging Systems), By Gamma Camera Imaging Systems, By...
20170406 Telix Logo.png
Telix In-Licences Novel Tumour Microenvironment PET Tracer
September 09, 2021 01:34 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIÈGE, Belgium, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an exclusive...
22157.jpg
The Worldwide Nuclear Imaging Equipment Industry is Projected to Reach $4.6 Billion by 2025 at a CAGR of 3.9% From 2020
March 12, 2021 08:18 ET | Research and Markets
Dublin, March 12, 2021 (GLOBE NEWSWIRE) -- The "Nuclear Imaging Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), Hybrid PET, & Planar Scintigraphy), Application (Oncology,...
Eckert & Ziegler’s GalliaPharm® distributed by Curium in France
March 01, 2021 19:15 ET | Curium
Berlin, Germany and Paris, France, March 01, 2021 (GLOBE NEWSWIRE) -- Eckert & Ziegler Radiopharma GmbH and Curium PET France have decided to reinforce their existing long term partnership by...
20170406 Telix Logo.png
First Patients Dosed in Phase III ZIRCON Trial of Renal Cancer Imaging Product in Turkey
October 22, 2020 01:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and ISTANBUL, Turkey, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) and Eczacıbaşı-Monrol Nuclear Products Co. (‘Eczacıbaşı...
20170406 Telix Logo.png
Telix Pharmaceuticals and GE Healthcare: Maximising 68Ga Supply for Prostate Cancer Imaging
October 13, 2019 19:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Oct. 14, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX, “Telix”, the “Company”) a clinical-stage biopharmaceutical company focused on the development of...
20170406 Telix Logo.png
Telix Pharmaceuticals to Launch Japanese Renal Cancer Imaging Study
August 29, 2019 20:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO, Japan, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the...
20170406 Telix Logo.png
Telixが日本で腎臓がん用画像診断薬の臨床治験を開始
August 29, 2019 20:00 ET | Telix Pharmaceuticals Limited
メルボルン, オーストラリア および京都, 日本, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals...
20170406 Telix Logo.png
Telix Pharmaceuticals and GenesisCare Commence ENHANCING Prostate Cancer Clinical Study
August 07, 2019 20:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and SYDNEY, Australia, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on...